Followers | 437 |
Posts | 42954 |
Boards Moderated | 2 |
Alias Born | 05/08/2006 |
Tuesday, September 08, 2015 2:47:19 PM
GrowBLOX Sciences, a biopharmaceutical company with cutting-edge technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today named former Nevada State Senator Sandra Tiffany as general manager of GB Sciences Nevada, LLC.
During her 14 years in the legislature, Tiffany held numerous leadership roles and authored key “game changing” legislation. She has been honored in her community and served on a number of boards and non-profit advisory boards. Specifically relative to GrowBLOX operations, Tiffany was in office when Nevada voters approved the “Medical Marijuana Act.”
Tiffany also has an extensive history as an entrepreneur. Before the age of 30 she established her first company, Computer Methods Inc., in which Tiffany developed and marketed a system for nuclear medicine image processing. She then parlayed that success by joining Intergraph, a computer-aided design and engineering Fortune 500 firm. During Tiffany’s 35 years of business experience, she created and managed her own companies that vary from an Internet café to government affairs.
For the last 11 years, Tiffany has been involved in the payment processing area, and has developed a large client list and built extensive relationships with local and national financial communities.
GrowBLOX anticipates that Tiffany’s combined experiences will be a valued and complementary fit for the company’s growth goals.
Craig Ellins, chief executive officer of GrowBLOX Sciences, in the news release stated, “We expect former Senator Tiffany to play a key role as we move GrowBLOX Sciences from the developmental stage to one of commercial success. We believe that the important development of true medicine will be based on our advanced technology and superior products.”
Likewise, Tiffany noted her pleasure at working with the GrowBLOX team to advance its cannabis cultivation technologies.
“I am excited to join GrowBLOX Sciences, having long admired their commitment to the careful scientific study of the cannabis plant and by the opportunity to work with my longtime friend Craig Ellins,” she said.
For more information visit www.growblox.com
Recent GBLX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:15:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:31:48 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2023 08:18:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 08:12:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/30/2023 12:00:24 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM